BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15119700)

  • 1. Dynamic assessment of myocardial involvement in patients with end-stage renal disease by ultrasonic tissue characterization and serum markers of collagen metabolism.
    Fatema K; Hirono O; Masakane I; Nitobe J; Kaneko K; Zhang X; Takeishi Y; Kubota I
    Clin Cardiol; 2004 Apr; 27(4):228-34. PubMed ID: 15119700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodialysis improves myocardial interstitial edema and left ventricular diastolic function in patients with end-stage renal disease: noninvasive assessment by ultrasonic tissue characterization.
    Fatema K; Hirono O; Takeishi Y; Nitobe J; Kaneko K; Ito M; Masakane I; Kubota I
    Heart Vessels; 2002 Sep; 16(6):227-31. PubMed ID: 12382031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy.
    Schwartzkopff B; Fassbach M; Pelzer B; Brehm M; Strauer BE
    Eur J Heart Fail; 2002 Aug; 4(4):439-4. PubMed ID: 12167381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment with valsartan improved cyclic variation of the myocardial integral backscatter signal and diastolic dysfunction in hypertensive patients: the echocardiographic assessment.
    Mizuta Y; Kai H; Mizoguchi M; Osada K; Tahara N; Nakaura H; Kuwahara F; Imaizumi T;
    Hypertens Res; 2008 Oct; 31(10):1835-42. PubMed ID: 19015589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac cyclic variation of integrated backscatter in hypertension and dialysis patients.
    Akar H; Ceyhan C; Yenicerioglu Y; Keven K; Onbasili A; Tekten T
    J Nephrol; 2004; 17(2):270-4. PubMed ID: 15293528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial ultrasound tissue characterization in patients with chronic renal failure.
    Salvetti M; Muiesan ML; Paini A; Monteduro C; Bonzi B; Galbassini G; Belotti E; Movilli E; Cancarini G; Agabiti-Rosei E
    J Am Soc Nephrol; 2007 Jun; 18(6):1953-8. PubMed ID: 17442790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
    Ahmed SH; Clark LL; Pennington WR; Webb CS; Bonnema DD; Leonardi AH; McClure CD; Spinale FG; Zile MR
    Circulation; 2006 May; 113(17):2089-96. PubMed ID: 16636176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of thrice-weekly in-center nocturnal vs. conventional hemodialysis on integrated backscatter of myocardial tissue.
    Jin X; Rong S; Mei C; Ye C; Chen J; Chen X
    Hemodial Int; 2011 Apr; 15(2):200-10. PubMed ID: 21395972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities of the extracellular degradation of collagen type I in essential hypertension.
    Laviades C; Varo N; Fernández J; Mayor G; Gil MJ; Monreal I; Díez J
    Circulation; 1998 Aug; 98(6):535-40. PubMed ID: 9714110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of preload reduction by hemodialysis on myocardial ultrasonic characterization, left atrial volume, and Doppler tissue imaging in patients with end-stage renal disease.
    Fijalkowski M; Koprowski A; Gruchala M; Galaska R; Debska-Slizien A; Rogowski J; Rutkowski B; Rynkiewicz A
    J Am Soc Echocardiogr; 2006 Nov; 19(11):1359-64. PubMed ID: 17098139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Hemodialysis Corrects Left Ventricular Dyssynchrony in End-stage Renal Disease: A Study with Gated Technetium-99m Sestamibi Myocardial Perfusion Single-photon Emission Computed Tomography.
    Takahashi N; Sato N; Ishikawa M; Kikuchi A; Hanaoka D; Ishihara S; Amitani K; Sakai Y; Kumita S; Shimizu W
    J Nippon Med Sch; 2015; 82(2):76-83. PubMed ID: 25959198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relations of serum MMP-9 and TIMP-1 levels to left ventricular measures and cardiovascular risk factors: a population-based study.
    Hansson J; Lind L; Hulthe J; Sundström J
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):297-303. PubMed ID: 19387352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of matrix metalloproteinases and their tissue inhibitors as potential biomarkers of left ventricular remodelling in the athlete's heart.
    Vianello A; Caponi L; Franzoni F; Galetta F; Rossi M; Taddei M; Malvaldi G; Pietrini P; Santoro G
    Clin Sci (Lond); 2009 Jul; 117(4):157-64. PubMed ID: 19196241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symmetric and asymmetric left ventricular hypertrophy in patients with end-stage renal failure on long-term hemodialysis.
    Straumann E; Bertel O; Meyer B; Weiss P; Misteli M; Blumberg A; Jenzer H
    Clin Cardiol; 1998 Sep; 21(9):672-8. PubMed ID: 9755385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Angiotensin II type 1 antagonist suppress left ventricular hypertrophy and myocardial fibrosis in patient with end stage renal disease (ESRD)].
    Shibasaki Y; Nishiue T; Masaki H; Matsubara H; Iwasaka T
    Nihon Rinsho; 2002 Oct; 60(10):1992-8. PubMed ID: 12397697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A
    J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue inhibitor of metalloproteinases (TIMP-1), genetic markers of insulin resistance and cardiomyopathy in patients with kidney failure.
    Spoto B; Testa A; Parlongo RM; Tripepi G; D'Arrigo G; Mallamaci F; Zoccali C
    Nephrol Dial Transplant; 2012 Jun; 27(6):2440-5. PubMed ID: 22199358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A; Naderi AS
    Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the angiotensin II receptor antagonist, losartan, on myocardial fibrosis in patients with end-stage renal disease: assessment by ultrasonic integrated backscatter and biochemical markers.
    Shibasaki Y; Nishiue T; Masaki H; Tamura K; Matsumoto N; Mori Y; Nishikawa M; Matsubara H; Iwasaka T
    Hypertens Res; 2005 Oct; 28(10):787-95. PubMed ID: 16471172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular remodeling, mechanics, and tissue characterization in congenital aortic stenosis.
    Pacileo G; Calabrò P; Limongelli G; Russo MG; Pisacane C; Sarubbi B; Calabrò R
    J Am Soc Echocardiogr; 2003 Mar; 16(3):214-20. PubMed ID: 12618728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.